EN
HI
Ipca Laboratories Chart
Ipca Laboratories Share Key Metrics
Volume
1.96 L
Market Cap
39182.08 CR
LTQ@LTP
2@1528.00
ATP
1537.68
Var Margin
16.01 %
Circuit Range
1235.6-1853.2
Delivery %
22.98 %
Value
30.14 CR
ASM/GSM
No
Market Lot
1
Summary
At 20 Mar, 2026 | 15:29, Ipca Laboratories share price stands at ₹1528, showing a 16.40% -1.06 for the day. The stock’s intraday movement has stayed between ₹1505.50 and ₹1575.80, while on a 52-week basis it has fluctuated from ₹1168.20 to ₹1624.00.
In terms of trading activity, Ipca Laboratories has recorded a volume of 196011 shares, with a market capitalisation of ₹253704218. The stock’s Average Traded Price (ATP) stands at ₹153768, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2,152800. The stock operates within a circuit range of ₹1235.6-1853.2, with a Value of ₹30.14 CR. The Delivery Percentage for the day is 22.98%. Additionally, Ipca Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Ipca Laboratories Fundamentals
View MoreP/E Ratio
43.1
P/B Ratio
5.03
Div. Yield
0.26
Sector P/E
59.61
Sector P/B
2.6
Sec. Div. Yield
0.59
Ipca Laboratories Resistance and Support
Pivot 1546.5
Resistance
First Resistance
1583.9
Second Resistance
1623.4
Third Resistance
1660.8
Support
First Support
1507
Second Support
1469.6
Third Support
1430.1
Ipca Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
Ipca Laboratories News
Ipca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Ipca Labs released its Q3 FY26 earnings conference call transcript, reporting ~6.5% consolidated business growth to ₹2,393 crores. The company also saw a 2.28% improvement in consolidated EBITDA margin to 22.5% for the quarter, driven by strong domestic and export formulation performance.
Feb 18 2026 13:02:00
Read More
About Ipca Laboratories
NSE : 1633
BSE : 524494
ISIN : INE571A01038
Ipca Laboratories Management
| Name | Position |
|---|---|
| Mr. Premchand Godha | Executive Chairman |
| Mr. Ajit Kumar Jain | Managing Director & CFO |
Ipca Laboratories Similar Stocks
Biocon Ltd.
380.95
12.40 (3.36%)
Glenmark Pharmaceuticals Ltd.
2180.10
82.60 (3.94%)
Abbott India Ltd.
26715.00
200.00 (0.75%)
Laurus Labs Ltd.
987.20
42.30 (4.48%)
Glaxosmithkline Pharmaceuticals Ltd.
2384.80
8.10 (0.34%)
Ajanta Pharma Ltd.
2904.70
-39.20 (1.33%)
Anthem Biosciences Ltd.
644.85
9.35 (1.47%)
Narayana Hrudayalaya Ltd.
1652.20
3.90 (0.24%)
Aster DM Healthcare Ltd.
626.95
-9.25 (1.45%)
JB Chemicals & Pharmaceuticals Ltd.
2138.60
53.70 (2.58%)
Ipca Laboratories FAQs
The Buying Price of Ipca Laboratories share is 1528 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ipca Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ipca Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ipca Laboratories shares is 43.1. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ipca Laboratories shares is 5.03. Useful to assess the stock's value relative to its book value.
To assess Ipca Laboratories’s valuation compare Sector P/E, P/B which are 59.61 & 2.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ipca Laboratories is 39182.08 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ipca Laboratories share price is 1624.00 & 1168.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ipca Laboratories belongs to the Healthcare sector.
